WilmerHale invites you to join a timely webinar examining recent developments related to Section 232 tariffs on pharmaceuticals and their potential impact on the life sciences sector.

This program will feature WilmerHale Partners Neena Shenai and Liz Lindquist, who will provide practical insights into the administration's evolving approach to Section 232 measures and what companies should be monitoring in the weeks ahead.

Topics will include:

• the current status of Section 232 pharmaceutical tariff actions and related investigations;
• key legal, regulatory and trade policy considerations for companies operating in the life sciences sector; and
• practical considerations for businesses seeking to assess potential supply chain and compliance impacts.

During the webinar, participants will have the opportunity to submit questions online. CLE credit is pending for this webinar.

Webinar Details:
Wednesday, August 5, 2026  |  12–1 p.m. ET